CAMPSQ20221
Title : Defensin-derived D-Peptide B
Source : Synthetic construct
PubMed : 19584534, 15003352, 19154767
Activity : Antibacterial, Antiparasitic
Gram Nature : Gram+, Gram-
Target :
Staphylococcus aureus KO-4[MIC = 600 microg/ml], Pseudomonas aeruginosa[MIC = 800 microg/ml], Trypanosoma brucei brucei GUT Tat3.1[MIC = 500 microM], Staphylococcus aureus ATCC 6538P[MIC = 1 microg/ml], Staphylococcus aureus ATCC 6538P[MIC = 2 microg/ml], Escherichia coli JM109[MIC = 2 microg/ml], Escherichia coli JM109[MIC = 20 microg/ml], Trichophyton mentagrophytes IFO 5466[MIC = 50 microg/ml], Staphylococcus aureus KO-4[MIC = 30 microg/ml], Pseudomonas aeruginosa[MIC = 100 microg/ml], Trypanosoma brucei brucei GUT Tat3.1[MIC = 90+-31 microM], Mouse myeloma P3-X63-Ag8.653[IC50 = 28+-2 microM], Human cervical carcinoma HeLa[IC50 = 188+-32 microM], African green monkey kidney cancer Cos-1[IC50 = 344+-82 microM], Human squamous carcinoma RERF-LC-AI[IC50 = 405+-16 microM], Human glioblastoma U251-MG[IC50 = 442+-57 microM], Human lung cancer VA-13[IC50 >640 microM]
Validated : Experimentally Validated
Comment : Has anticancer activity
Length : 9
Sequence:
RLRLRIGRR

| © 2022, Biomedical Informatics Centre, ICMR-NIRRCH |
ICMR-National Institute for Research in Reproductive and Child Health, Jehangir Merwanji Street, Parel, Mumbai-400012
Maharashtra, India